Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 270 Stomach Neoplasms 200 Rectal Neoplasms 180 Pancreatic Neoplasms 131 Colonic Neoplasms 112 Neoplasm Metastasis 74 Esophageal Neoplasms 63 Carcinoma, Hepatocellular 41 Neoplasms 40 Cholangiocarcinoma 36 Adenocarcinoma Of Esophagus 32 Adenocarcinoma 32 Biliary Tract Neoplasms 25 Liver Neoplasms 21 Gallbladder Neoplasms 21 Recurrence 18 Gastrointestinal Neoplasms 18 Lymphoma, Large B-Cell, Diffuse 17 Peritoneal Neoplasms 16 Carcinoma, Non-Small-Cell Lung 16 Breast Neoplasms 16 Esophageal Squamous Cell Carcinoma 14 Locally Advanced Rectal Cancer 12 Bile Duct Neoplasms 11 Colorectal Cancer Metastatic 8 Unspecified Adult Solid Tumor, Protocol Specific 7 Ovarian Neoplasms 7 Lymphoma, Extranodal NK-T-Cell 7 Head and Neck Neoplasms 7 Appendiceal Neoplasms 7

Interventions

Radiotherapy 4 Immune Checkpoint Inhibitors 4 Oxaliplatin 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced NSCLC × Oxaliplatin × Clear all

NCT04043195 2025-05-28

NSCLC

University of California, San Diego

Phase 1/2 Active not recruiting

Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡